Meraviglia, S.
119  results:
Search for persons X
?
3

P008 Common and different inflammatory features in inflamma..:

Lo Presti, E. ; Di Mitri, R. ; Dieli, F....
Journal of Crohn's and Colitis.  11 (2017)  suppl_1 - p. S83-S83 , 2017
 
?
 
?
5

In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and..:

Meraviglia, S ; Eberl, M ; Vermijlen, D...
Clinical and Experimental Immunology.  161 (2010)  2 - p. 290-297 , 2010
 
?
6

In Vitro Effects of Aminobisphosphonates on Vγ9Vδ2 T Cell A..:

Ferlazzo, V. ; Sferrazza, C. ; Caccamo, N....
International Journal of Immunopathology and Pharmacology.  19 (2006)  2 - p. 309-317 , 2006
 
?
7

A Human Leucocyte Antigen‐DR1 Transgene Confers Susceptibil..:

Sireci, G. ; Dieli, F. ; Caccamo, N....
Scandinavian Journal of Immunology.  58 (2003)  2 - p. 188-194 , 2003
 
?
8

Cytokine profile, HLA restriction and TCR sequence analysis..:

CACCAMO, N ; BARERA, A ; DI SANO, C...
Clinical and Experimental Immunology.  133 (2003)  2 - p. 260-266 , 2003
 
?
9

Impact of the flame retardant 2,2'4,4'-tetrabromodiphenyl e..:

Longo V ; Aloi N ; Lo Presti E...
info:eu-repo/semantics/altIdentifier/pmid/36685495.  , 2023
 
?
 
?
11

Vitamin C as a promoter of γδ T cells:

Meraviglia S ; Dieli F
info:eu-repo/semantics/altIdentifier/pmid/32999456.  , 2021
 
?
 
?
14

Nivolumab in metastatic melanoma: good efficacy and tolerab..:

De Luca, R ; Meraviglia, S ; Blasi, L..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253741/.  , 2020
 
?
 
1-15